QuriousRI’s Nitrosamine assessment tool is part of global regulatory strategy platform offering a single platform for evidence-based, audit-ready decision support for nitrosamine assessment across multiple jurisdictions. The platform acts as single source to minimize manually cross checking across countries, enable centralized tracking, consistent system for faster time to market and compliance through new registrations or variations management.
Key Benefits of the QuriousRI Nitrosamine Assessment Tool
- Single Platform – Multiple Jurisdictions: The platform offers single platform for evaluation of nitrosamine guidance and acceptable limits across multiple agencies including, USA, EU, UK, Canada, Australia, Brazil, China and others.
- Consistent, Auditable: Standardized risk assessment approach across markets and portfolio with audit trail
- Deadline Visibility and Notifications: Centralized tracking of deadlines across health agencies / countries triggering alerts for timely submissions / reporting.
- Faster Time to Market and Ongoing Compliance: Re-use risk assessment logic with country specific variations for new registration and variations filing.
Key Features of the QuriousRI Nitrosamine Assessment Tool
Multi-Agency Nitrosamine Regulatory Requirements Tracker
- Track country-wise guidance documents, triggers for applicability, submissions deadlines and other key updates in single platform
- Track changes in regulations, acceptable intakes globally
Compound Specific Acceptable Limit / Daily Limit Database
- Global repository, searchable by nitrosamine compound and by health authority/country
- Side-by-side cross-country/ agency comparison of limits for each compound / portfolio
- Identification of CPCA / read across instances where compound specific limit is not provided
Stepwise Nitrosamine Risk Assessment Identification Workflow Engine
- Guided workflow including three step approach of risk assessment, testing decisions as per country / agency expectations
Portfolio Risk Categorization Dashboard
- Compound / molecule level and portfolio level, market risk status dashboard
- Dashboard filters include market, dosage form, synthesis route etc.
Deadline Tracker and Automated Alerts
- Track country specific submissions and reporting deadlines for each product
- Automated alerts for deadlines
Conclusion
Managing nitrosamine requirements across multiple markets can become difficult when guidance, acceptable intake limits, testing expectations and submission deadlines vary by authority. QuriousRI’s Nitrosamine Assessment Tool brings these requirements into one place, supporting consistent risk assessment, country-specific comparisons, deadline tracking, and portfolio-level compliance monitoring.
Explore QuriousRI to access regulatory intelligence, monitoring, alerts and risk-impact analysis across global markets, including nitrosamine assessment and other regulatory requirements.
FAQs
1. What are nitrosamines, why nitrosamine risk assessment is important and what do agencies expect?
Nitrosamines (N-nitroso compounds) are a class of chemical impurities identified and classified as probable human carcinogens based on animal carcinogenicity data. Nitrosamines are formed when a secondary or tertiary amine reacts with nitrosating agent. They may arise during different stages of API or finished drug manufacturing, packaging etc. Nitrosamines are regulated under the ICH M7 mutagenic impurity framework and inability to comply with requirements have significant regulatory and business risks for manufacturers.
Globally, agencies have a shared expectation on a stepwise risk based approach including risk evaluation (whether nitrosamine formation is plausible during any stage/process), confirmatory testing using validated methods if risk identified and risk mitigation through specifications/process changes etc as applicable and reporting to the agencies.
2. What does the Nitrosamine Assessment tool actually do?
QuriousRI’s nitrosamine assessment tool provides single platform for identified acceptable intake limits for nitrosamine compounds across health agencies and applicable guidelines for evaluation of risks and mitigation requirements. The tool also helps in tracking deadlines across agencies providing a centralized dashboard to monitor and manage nitrosamine compliance across products portfolio in global markets.
3. Which markets are covered in the tool?
The tool currently covers all major markets and stringent authorities such as US FDA, EU EMA, UK MHRA, Australia TGA, Brazil ANVISA, China NMPA and others. The tool is continuously updated with new regulations / guidelines from 100+ markets related to nitrosamine with assessment available for specific countries.
